Top Tech Companies (1,864)
Don't see your company?
Create a company profile
ThreatX is managed API and application protection that lets you secure them with confidence, not complexity. It blocks botnets and advanced attacks in real time, letting enterprises keep attackers at bay without lifting a finger. Trusted by companies in every industry across the globe, ThreatX profiles attackers and blocks advanced risks to protect APIs and applications 24/7. Learn more at https://www.threatx.com.
Prime Medicine was founded to bring the promise of gene editing to patients. We use Prime Editing, a next-generation technology that can “search and replace” to restore normal genetic function almost anywhere in the genome. Prime Editing searches to find the precise place in the genome to edit and replaces the segment of faulty DNA with a correct copy of DNA. A single Prime Editor can correct the individual mutations found across patients, meaning Prime Editing can potentially address more than 90 percent of known disease-causing genetic mutations. We envision a world where this technology can cure, halt, and ultimately prevent genetic diseases, providing lifelong benefit to patients. Prime Medicine offers the opportunity to shape the future of gene editing and transform how medicines are used to treat disease. Realizing the promise of Prime Editing requires a talented team with diversity of viewpoints and expertise. We’re building a group of dedicated, scientifically curious individuals who are passionate about helping patients live longer, healthier lives.
TileDB, Inc. was spun out of MIT and Intel Labs in May 2017 as a database built on an open array engine to structure complex data for optimized cloud compute and analytics. The company's flagship product, TileDB Cloud, streamlines data management and provides extreme performance at any degree of dimensionality, and at any scale. TileDB also develops a wide range of open-source tools for interoperability across the data science and scientific computing ecosystems. TileDB is backed by Two Bear Capital, Nexus Venture Partners, Uncorrelated Ventures, Intel Capital and Big Pi. Start for free by signing up at cloud.tiledb.com.
Cytel enables decision-makers in the life sciences to unlock the full potential of their products. From navigating uncertainty to proving value, Cytel’s 30 years of global expertise in consulting, data-driven analytics, and industry-leading software helps biotech and pharmaceutical companies transform intelligence into confident decisions. We have an uncompromising commitment to scientific rigor and high standards of operational excellence, which are channeled through our locations in North America, Europe, the United Kingdom, and Asia. Together, we enable our clients to deliver the therapies that propel humanity forward. Cytel employs a range of data science tools from biostatistics to machine learning to help executives in the life-sciences to make confident decisions powered by data. We are probably best known for being leaders in the field of adaptive clinical trial design, a subset of trial design that uses interim looks to enhance the patient safety and commercial value of pharmaceutical products. We also have specialists in Bayesian statistics, real world evidence, artificial intelligence, health economics, and a number of other research fields to ensure that academic and scientific findings can have impact on industry quickly and seamlessly. www.cytel.com
iuvo Empowers Your Business Through Technology We are customer-service obsessed Our experts have an exceptional personal commitment to providing the best customer experience. In fact, iuvo is a latin word that means “to help, assist, delight or gratify. We are your trusted business partner Our experts provide PROACTIVE, PRACTICAL and CUSTOMIZED EXPERTISE, applicable to YOUR business situation. We have your back! We hire the BEST people Our rock-star IT professionals have a unique combination of people skills and technology experience. We offer comprehensive IT solutions. Our breadth, depth and collaborative culture ensures you get the RIGHT answers, FAST. @iuvotech
argenx is a global immunology company committed to improving the lives of people living with severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx is translating immunology breakthroughs into a world-class portfolio of novel antibody-based medicines.
Life's stressful, dinner shouldn't be. Every week, our chefs drop a menu chock full of feel-good, crave-able dinners that take less than 10 minutes to prep. WECO is hand-delivered daily throughout New England. Drop your email at www.wecohospitality.com to get the menu.
Tango Therapeutics is a biotechnology company discovering and developing novel medicines targeting cancer vulnerabilities to deliver transformational new therapies for patients. Tango was launched in 2017 with a $55 million Series A investment from Third Rock Ventures. The company has established a robust product engine that leverages advances in DNA sequencing and CRISPR-based target discovery to generate breakthrough medicines that have the potential to provide deeper, more sustained benefit than today’s targeted therapies, and extend the benefit of available immuno-oncology agents. Tango Therapeutics is focused on three areas of drug development, each in well-defined patient populations currently lacking effective treatment options, and each with hallmarks of cancer that have not been targeted yet. These include: loss of tumor suppressor gene function; multiple oncogenic drivers; and immune evasion. What fuels each of Tango’s programs is an increasingly sophisticated ability to utilize synthetic lethality - the interaction between two genes that causes cell death when both are inactivated. In cancer cells, one of these genes is inactivated by mutation; the other will be inactivated by a drug. This approach leaves normal cells largely unaffected, with the potential to greatly enhance anti-tumor efficacy and reduce associated toxicity. Tango’s success will be driven by its depth of understanding of the genetic subtypes of cancer, and corresponding insights into novel drug targets and combinations uniquely relevant to each subtype. By shaping discovery efforts in this way, Tango has the potential to reach the clinic quickly, and with a clear plan for identifying the patients most likely to benefit from each new treatment, an approach that could increase both speed and probability of success in translating novel target discoveries into transformational new medicines for patients.
Summize is pioneering true digital contracting with a CLM solution that puts the user experience first. It takes a deliberately different approach by embedding workflows directly into existing technologies that you (and your business) already know and use daily, including Teams, Slack and Word. This unique approach enables greater user adoption, faster contract cycles, measurable efficiencies, and mitigated risk. Now, in-house legal teams can instantly bring to life the contents of a contract with AI-powered metadata summaries, saving hours in manual review time. Comprehensive analytics and centralised repository provide all the insight to make informed decisions. It’s CLM with a difference
CKEditor provides a text editor that makes it easier for software development teams to work together and integrates with modern tech stacks.
.jpeg)
.jpg)
.jpg)
Portal Innovations is a venture capital firm that helps exceptional life sciences innovators build their companies where they live. We surround these entrepreneurs with the resources and community they need: Seed capital, fully equipped lab space, and expertise and introductions to other investors and partners.
Discover how Excelra, a leader in biopharma data and analytics, uniquely blends scientific understanding with technological expertise. This dual mastery empowers innovative drug discovery and development, transforming research data into actionable insights for groundbreaking discovery. 𝗘𝗺𝗽𝗼𝘄𝗲𝗿𝗶𝗻𝗴 𝗗𝗲𝗰𝗶𝘀𝗶𝗼𝗻𝘀 𝘄𝗶𝘁𝗵 𝗘𝘅𝗽𝗲𝗿𝘁𝗶𝘀𝗲 Excelra’s interdisciplinary approach combines life science expertise with cutting-edge technology. This leads to confident, data-centric decisions, simplifying your data-driven drug discovery journey and accelerating your research. 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝘃𝗲 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 𝗳𝗼𝗿 𝗘𝗻𝗵𝗮𝗻𝗰𝗲𝗱 𝗖𝗮𝗽𝗮𝗯𝗶𝗹𝗶𝘁𝗶𝗲𝘀 At Excelra, collaboration is key. By co-creating solutions, we amplify your team's capabilities, blending scientific insight and technological acumen for more valuable discoveries and greater project control. 𝗙𝗿𝗼𝗺 𝗖𝗵𝗮𝗼𝘀 𝘁𝗼 𝗖𝗹𝗮𝗿𝗶𝘁𝘆: 𝗦𝘁𝗿𝘂𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗗𝗮𝘁𝗮 We navigate the complexities of drug discovery, enhancing your success by structuring chaotic data into actionable insights, leveraging our scientific and technological prowess. 𝗖𝗼𝗺𝗺𝗶𝘁𝘁𝗲𝗱 𝘁𝗼 𝗬𝗼𝘂𝗿 𝗚𝗼𝗮𝗹𝘀 Your goals of faster drug development and better patient outcomes are central to our mission. Committed to delivering insights and tangible progress, we ensure each data point contributes to your innovation journey, helping you 'Excelrate' towards success. 𝗥𝗲𝗱𝗲𝗳𝗶𝗻𝗶𝗻𝗴 𝗗𝗿𝘂𝗴 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗧𝗼𝗴𝗲𝘁𝗵𝗲𝗿 Join us in redefining drug development. Our services span across the life science value chain, from molecule to market. At Excelra, each data point is a step towards a healthier future. Discover how partnering with us can 'Excelrate' your healthcare innovations.
LTI (Logic Technology Inc.) is a privately held information technology consulting firm headquartered in Schenectady, NY. Founded in 1989, LTI provides high-quality, cost-effective consulting services to major clients throughout the United States and globally. Built upon a foundation of technical prowess and a client-centered environment, we have earned a strong reputation for providing high-quality, cost-effective services to major clients throughout the Americas and Europe. From large multi-national, global enterprises to strategic government agencies, our current client list includes representation from both Fortune’s Top 10 and its list of “Most Admired” companies. OUR TOOLS FOR SUCCESS LTI has consistently provided our clients with value, dependability and quality in the delivery of enterprise-level outsourced services. We take pride in offering our clients flexibility and agility in the development of creative solutions to better serve the ever-changing demands of their business. We’re able to offer superior service and consistently outperform competitors because we work diligently to attract and retain the best and the brightest minds in the industry
Teradyne brings high-quality innovations such as smart devices, life-saving medical equipment and data storage systems to market, faster. Its advanced test solutions for semiconductors, electronic systems, wireless devices and more ensure that products perform as they were designed. Its robotics offerings include collaborative and mobile robots that help manufacturers of all sizes improve productivity and lower costs. Teradyne employs over 6,500 people worldwide. The Semiconductor Test Division is the world's largest supplier of semiconductor test equipment for logic, RF, analog, power, mixed-signal and memory technologies. The System Test Group is a global leader in electronics testing solutions serving the world's leading original equipment manufacturers, electronics manufacturing services suppliers, and hard disk drive makers. The Wireless Test segment, LitePoint, is focused on reducing the time to market and cost of system level test for wireless products operating on WiFi, Bluetooth, GPS, and cellular phone networks. Teradyne Robotics, consisting of Universal Robots and MiR, provides low-cost, easy-to-deploy and simple-to-program robots that work side by side with production workers to improve quality and increase manufacturing efficiency.
Our goal is to enable the analysis of anything, anywhere, by anyone. We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data. We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society. Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide. Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.
Total Quality Logistics (TQL) is the largest privately held freight brokerage firm in the nation. We help you find the right solution for your local, national and North American truckload freight and shipping needs.
Who we are: We’re not your average startup incubator. We think bigger than that. We aspire to be at the nexus of innovation and entrepreneurship. Located in the heart of Cambridge, Massachusetts, we capitalize on our proximity to successful technologists and organizations to foster the next generation of leaders at the forefront of consumer technology. We’re building companies, accelerating careers, and pioneering innovative, data-driven ways to transform the Boston tech community and entrepreneurial ecosystem around us. What we do: We’re on a mission to de-risk entrepreneurship by analyzing billions of data points to build and scale efficient, mission-driven companies that never fail to delight consumers. In a world where access to capital is biasing which populations can pursue entrepreneurship, we give smart, innovative founders the tools they need to test their offerings based on merit. Over the past twelve years, we’ve created the technology and processes to incubate successful companies, and we’re just getting started. Why we do it: We know that innovative ideas come from anywhere. That’s why we stay passionately curious. The companies we incubate are only as innovative as the breadth of lived experiences shared by the teams developing them. We aspire to transform the way that companies are built by creating a culture of innovation, collaboration, and inclusivity that extends beyond our four walls.
Our mission is to make the world a safe place. We live out our mission by empowering commercial insurance brokers and policyholders to better predict and prevent loss through AI-driven Smart Commercial Insurance® policies. We’re inspired by the intelligent, tool-building corvid family of birds that gives us our name.
At iZotope, we’re obsessed with great sound. Our intelligent audio technology helps musicians, music producers, and audio post engineers focus on their craft rather than the tech behind it. We design award-winning software, plug-ins, hardware, and apps powered by quality audio processing, machine learning, and strikingly intuitive interfaces.
Founded in 1999, Quickbase has since become the leading no-code platform for complex project portfolios. Its platform empowers its more than 6,000 customers to see, connect, and control their processes, applications, software, and data all in one centralized location. Named an Inc’s Best Businesses of 2022, see for yourself why Quickbase is at the forefront of business-led innovation at Quickbase.com. Quickbase – All together now.
